Home › NDC Lookup › RxCUI directory › RxCUI 856769

Amitriptyline hydrochloride 12.5 MG / chlordiazepoxide 5 MG Oral Tablet — RxCUI 856769

RxNorm drug concept · Semantic clinical drug
RxCUI 856769 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI856769
Official nameAmitriptyline hydrochloride 12.5 MG / chlordiazepoxide 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aschlordiazePOXIDE 5 MG / amitriptyline HCl 12.5 MG Oral Tablet
FDA products mapped2
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Chlordiazepoxide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Chlordiazepoxide is mainly used for three things: managing anxiety disorders, easing the symptoms of going through alcohol withdrawal, and calming pre-surgery anxiety. It's not mea...
  • What exactly is chlordiazepoxide used for?
  • Please don't stop on your own — this is one of the most important things to know about this medicine. Your body can become physically dependent on chlordiazepoxide, and stopping su...
  • Can I stop taking it whenever I want if I feel better?
📖 Read our full Chlordiazepoxide guide →

🕸️ Concept Web — How Amitriptyline hydrochloride 12.5 MG / chlordiaze... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Amitriptyline hydrochloride 12.5 MG / chlordiazepoxide 5 MG Oral Tablet RxCUI 856769

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Amitriptyline 704
    • Chlordiazepoxide 2356
    • Amitriptyline / chlordiazepoxide 974990
    • Amitriptyline hydrochloride 203168
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Amitriptyline / chlordiazepoxide Oral Tablet 370571
    • Amitriptyline hydrochloride / chlordiazepoxide Oral Tablet 2649243
    • Amitriptyline / chlordiazepoxide Oral Product 1152267
    • Amitriptyline / chlordiazepoxide Pill 1152268
    • Amitriptyline hydrochloride / chlordiazepoxide Oral Product 2661511
    • Amitriptyline hydrochloride / chlordiazepoxide Pill 2661815
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Amitriptyline hydrochloride 12.5 MG 856768
    • Chlordiazepoxide 5 MG 315630

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Amitriptyline hydrochloride 12.5 MG SCDC · 856768
  • Chlordiazepoxide 5 MG SCDC · 315630
  • Amitriptyline / chlordiazepoxide Oral Tablet SCDF · 370571
  • Amitriptyline hydrochloride / chlordiazepoxide Oral Tablet SCDFP · 2649243
  • Amitriptyline / chlordiazepoxide Oral Product SCDG · 1152267
  • Amitriptyline / chlordiazepoxide Pill SCDG · 1152268
  • Amitriptyline hydrochloride / chlordiazepoxide Oral Product SCDGP · 2661511
  • Amitriptyline hydrochloride / chlordiazepoxide Pill SCDGP · 2661815

📦 FDA Products & Package NDCs

2 products · 4 package NDCs
4 package NDCs map to RxCUI 856769 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00378-0211-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0211-01) Chlordiazepoxide and Amitriptyline Hydrochloride Mylan Pharmaceuticals Inc. 1986-12-10
00378-0211-05 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0211-05) Chlordiazepoxide and Amitriptyline Hydrochloride Mylan Pharmaceuticals Inc. 1986-12-10
00378-0277-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0277-01) Chlordiazepoxide and Amitriptyline Hydrochloride Mylan Pharmaceuticals Inc. 1986-12-10
00378-0277-05 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0277-05) Chlordiazepoxide and Amitriptyline Hydrochloride Mylan Pharmaceuticals Inc. 1986-12-10
Observed labelers: Mylan Pharmaceuticals Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.